ArticleTransplantation and cellular therapy2026
System-level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated With High One-year Survival and Reduced Cost.
Shernan G Holtan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.